CDC Classifies Two Coronavirus Strains as 'Variants of Concern'
WEDNESDAY, March 17, 2021 -- Two coronavirus strains first detected in California have been classified as "variants of concern" by the U.S. Centers for Disease Control and Prevention.
The agency said the variants may be about 20 percent more transmissible and that some COVID-19 treatments may be less effective against them, CNN reported. However, the CDC did not say that vaccines would be completely ineffective against the two strains. Currently, no coronavirus variants have been classified as a "variant of high consequence," the highest threat level. That category would include variants shown to significantly reduce vaccine effectiveness.
Still, health officials are concerned that some antibody treatments may not work as well against the variants, which are officially called B.1.427 and B.1.429. Scientists have been monitoring the strains closely in California during the past few months. The U.S. Department of Health and Human Services (HHS) recently halted shipments of one COVID-19 antibody treatment to California, Nevada, and Arizona, where the variants are circulating widely, CNN reported.
Officials said that a COVID-19 therapy made by Eli Lilly, a combination of the drugs bamlanivimab and etesevimab, can still be ordered, and a different antibody treatment made by Regeneron Pharmaceuticals was also not affected by the HHS action.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, April 16, 2021 -- Grandmaternal perinatal serum dichlorodiphenyltrichloroethane (DDT) is associated with granddaughter adult obesity and early menarche, according to a...
FRIDAY, April 16, 2021 -- Researchers may have uncovered potential mechanisms contributing to "broken heart syndrome," according to a study published online March 26 in the...
FRIDAY, April 16, 2021 -- For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.